which was approved for SBS in adults in 2012 and children in 2019 – while AstraZeneca's GLP-1 drug Byetta/Bydureon (exenatide) has also been used off-label to treat the disorder. 9 Meters is ...

Obesity in children and adults leads to an increase ... such as Farxiga/Forxiga (dapagliflozin) and Bydureon (exenatide). In order to get ahead of these potential competitors, both Lilly and ...

Iceland’s minister for children and education has resigned after admitting she had a child with a teenager more than three and a half decades ago, according to Icelandic media. Ásthildur Lóa ...

Children’s behaviour can be improved if they eat fish twice a week, a new study has underscored. Researchers from the University of Bristol have found that children consuming at least two servings of ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

The wearable device combines expertise in ... Mar. 17, 2025 — Early-life adversity affects more than half of the world's children and is a significant risk factor for cognitive and mental health ...

Mothers affected by gestational diabetes can prevent their children from going on to develop preadolescent obesity by breastfeeding them rather than bottle feeding, research has shown. Women can also ...

See what the children of your favourite celebrity couples are getting up to. We share the cutest family snaps of celebrity children and babies that are fast becoming famous in their own right.

Although the former Fox News co-anchor tends to keep his family away from the spotlight, he has opened up about his children in past interviews and, occasionally, on social media. Now that he’s ...

Exelixis, Inc announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older with ...

Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...